Dr. Elisa K Brantly, MD Urology Medicare: Accepting Medicare Assignments Practice Location: 600 East Interstate 20, Stanton, TX 79782 Phone: 432-607-3644 |
News Archive
Naltrexone, an opioid antagonist approved in 1994 by the U.S. Food and Drug Administration for alcohol-dependence (AD) treatment, can reduce relapse rates among AD patients.
A team of researchers at Wayne State University's Parent Health Lab in the School of Medicine have developed a novel indirect screener that identifies women at risk for drug use by evaluating correlates of illicit drug use rather than drug use itself. In phase I testing, this new screener proved to be more sensitive than any alternative approach at detecting recent drug use.
The right way is to strengthen it, closing coverage gaps while also bringing down costs by improving care and reducing waste and fraud. Medicare's trustees estimate that the new health care law has already added eight years to the life of the Medicare trust fund by doing just that. The president's fiscal framework would put the program on even more solid ground in the future.
Arrowhead Pharmaceuticals Inc. today announced that it has completed dosing of a Phase 1 clinical study of ARO-AAT, the company's second generation subcutaneously administered RNA interference therapeutic being developed as a treatment for a rare genetic liver disease associated with alpha-1 antitrypsin deficiency.
Infectious diseases pose a serious threat to the nation's public health. Today, experts addressed key developments to the current and future outlook of infectious diseases, highlighting adolescent immunizations, outbreaks and epidemics of infectious diseases, antimicrobial resistance and new developments in HIV medicine, at a press conference sponsored by the National Foundation for Infectious Diseases (NFID).
› Verified 3 days ago